Vaxcyte
PCVX
#2300
Rank
NZ$14.38 B
Marketcap
NZ$99.59
Share price
4.58%
Change (1 day)
67.66%
Change (1 year)

Market capitalization of Vaxcyte (PCVX)

Market cap: NZ$14.38 Billion

As of July 2026 Vaxcyte has a market cap of NZ$14.38 Billion. This makes Vaxcyte the world's 2300th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vaxcyte from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$14.38 B35.45%
2025NZ$10.61 B-40.67%
2024NZ$17.89 B89.37%
2023NZ$9.44 B58.41%
2022NZ$5.96 B224.45%
2021NZ$1.83 B-2.01%
2020NZ$1.87 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Vaxcyte was reported to be:

NZ$14.38 Billion
by Nasdaq info icon info icon
NZ$14.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.92 B-86.62%๐Ÿ‡บ๐Ÿ‡ธ USA